announcement

Read about Simons Searchlight’s commitment to data privacy and security.

GENE GUIDE

MBD5-Related Syndrome

This guide is not meant to take the place of medical advice. Please consult with your doctor about your genetic results and health care choices. This Gene Guide was last updated in 2024. As new information comes to light with new research we will update this page. You may find it helpful to share this guide with friends and family members or doctors and teachers of the person who has MBD5-Related Syndrome.
a doctor sees a patient

MBD5-related syndrome is also called MBD5-associated neurodevelopmental disorder (MAND). For this webpage, we will be using the name MBD5-related syndrome to encompass the wide range of variants observed in the people identified.

MBD5-related syndrome happens when there are changes in the MBD5 gene. These changes can keep the gene from working as it should.

Key Role

The MBD5 gene plays a key role in the development and function of the brain. It is also important for other organs, including the heart and intestines.

Symptoms

Because the MBD5 gene is important for brain activity, many people who have MBD5-related syndrome have:

  • Developmental delay
  • Intellectual disability
  • Motor delay
  • Speech impairments
  • Seizures
  • Autism spectrum disorder
  • Behavioral issues, including sleep issues, repetitive behaviors, and short attention span
  • Low muscle tone
  • Smaller than average head size (microcephaly)
  • Walking or movement issues
  • Overeating or feeding challenges

MBD5-related syndrome is a genetic condition, which means that it is caused by variants in genes. Our genes contain the instructions, or code, that tell our cells how to grow, develop, and work. Every child gets two copies of the MBD5 gene: one copy from their mother’s egg, and one copy from their father’s sperm. In most cases, parents pass on exact copies of the gene to their child. But the process of creating the egg or sperm is not perfect. A change in the genetic code can lead to physical issues, developmental issues, or both. 

Sometimes a spontaneous variant happens in the sperm, egg or after fertilization. When a brand new genetic variant happens in the genetic code is called a ‘de novo’ genetic variant. The child is usually the first in the family to have the genetic variant.

De novo variants can take place in any gene. We all have some de novo variants, most of which don’t affect our health. But because MBD5 plays a key role in development, de novo variants in this gene can have a meaningful effect. 

Research shows that MBD5-related syndrome is often the result of a de novo variant in MBD5. Many parents who have had their genes tested do not have the MBD5 genetic variant found in their child who has the syndrome. In some cases, MBD5-related syndrome happens because the genetic variant was passed down from a parent.

Autosomal dominant conditions

MBD5-related syndrome is an autosomal dominant genetic condition. This means that when a person has the one damaging variant in MBD5 they will likely have symptoms of MBD5-related syndrome. For someone with an autosomal dominant genetic syndrome, every time they have a child there is a 50 percent chance they pass on the same genetic variant and a 50 percent chance they do not pass on the same genetic variant.

Autosomal Dominant Genetic Syndrome

GENE / gene
GENE / gene
Genetic variant that happens in sperm or egg, or after fertilization
GENE / gene
Child with de novo genetic variant
gene / gene
Non-carrier child
gene / gene
Non-carrier child

Why does my child have a change in the MBD5 gene?

No parent causes their child’s MBD5-related syndrome. We know this because no parent has any control over the gene changes that they do or do not pass on to their children. Please keep in mind that nothing a parent does before or during the pregnancy causes this to happen. The gene change takes place on its own and cannot be predicted or stopped.

What are the chances that other family members of future children will have MAND?

Each family is different. A geneticist or genetic counselor can give you advice on the chance that this will happen again in your family.

The risk of having another child who has MAND depends on the genes of both birth parents.

  • If neither birth parent has the same gene change found in their child, the chance of having another child who has the disorder is on average 1 percent. This 1 percent chance is higher than the chance of the general population. The increase in risk is due to the very unlikely chance that more of the mother’s egg cells or the father’s sperm cells carry the same change in the gene.
  • If one birth parent has the same gene change found in their child, the chance of having another child who has the disorder is 50 percent.

For a symptom-free sibling, a brother or sister, of someone who has MAND, the risk of having a child who has the disorder depends on the symptom-free sibling’s genes and their parents’ genes.

  • If neither parent has the same gene change found in their child who has the disorder, the symptom-free sibling has a nearly 0 percent chance of having a child who has MAND.
  • If one birth parent has the same gene change found in their child who has the disorder, the symptom-free sibling has a small chance of also having the same gene change. If the symptom-free sibling has the same gene change as their sibling who has the disorder, the symptom-free sibling’s chance of having a child who has MAND is 50 percent.

For a person who has MAND, the risk of having a child who has the disorder is about 50 percent.

As of 2026, about 175 people with MBD5-related syndrome have been identified in a medical clinic.

People with MBD5-related syndrome may look different. Appearance can vary and can include, but is not limited to, these features:

  • Smaller than average head size (microcephaly)
  • Thick and highly arched eyebrows
  • Forward-facing large earlobes
  • Noticeable ears
  • Short nose
  • Depressed or wide bridge of the nose
  • Downturned corners of the mouth
  • Thin border of the upper lip

Scientists and doctors have only just begun to study MBD5-related syndrome. At this point, there are no medicines designed to treat the disorder. A genetic diagnosis can help people decide on the best way to track the condition and manage therapies. Doctors can refer people to specialists for:

  • Physical exams and brain studies.
  • Genetics consults.
  • Development and behavior studies.
  • Other issues, as needed.

A developmental pediatrician, neurologist, or psychologist can follow progress over time and can help:

  • Suggest the right therapies. These can include physical, occupational, speech, or behavioral therapy.
  • Guide individualized education plans (IEPs).

Specialists advise that therapies for MBD5-related syndrome should begin as early as possible, ideally before a child begins school.

If seizures happen, consult a neurologist. There are many types of seizures, and not all types are easy to spot. To learn more, you can refer to resources such as the Epilepsy Foundation’s website: www.epilepsy.com/learn/types-seizures.

This section includes a summary of information from major published articles. It highlights how many people have different symptoms. To learn more about the articles, see the Sources and references section of this guide.

Learning and speech

Most people with MBD5-related syndrome had developmental delay and speech delay or impairment. Although children had motor, language, and social delays, they usually gained skills without regressions. The average age of walking was 2 to 3 years old. Most children did not speak or were able to speak in single words, short phrases, or sentences.

  • 100 percent of people had a developmental delay
  • 80 percent of people had a speech delay and/or language impairment

Behavior

Some people with MBD5-related syndrome had behavioral issues, such as autism or features of autism, attention-deficit/hyperactivity disorder (ADHD), repetitive behaviors (stereotypic behavior), self-injury and aggression, anxiety, inappropriate happy demeanor, and social withdrawal.

  • 100 percent of people had behavioral issues
  • 80 percent of people had repetitive behaviors
  • 60 percent of people had self-injury and aggression
100%
100 percent of people had behavioral issues
80%
80 percent of people had repetitive behaviors
60%
60 percent of people had self-injury and aggression

Brain

People with MBD5-related syndrome had neurological medical issues, including a small head size (microcephaly), low muscle tone (hypotonia), and seizures. Seizure onset usually occurred around 2 years old, with most people reporting 1 type of seizure.

  • 80 percent of people had microcephaly
  • 80 percent of people had hypotonia
  • 90 percent of people had seizures
Human head showing brain outline

Graphs

 
 
 

100%

80%

60%

40%

20%

0

Microcephaly
Hypotonia
Seizures

Other medical findings

People with MBD5-related syndrome often had feeding issues and constipation and many had skeletal defects. Skeletal changes included small hands and feet, the pinky finger curving at the joint, shorter fingers or toes, and a sandal gap (a wide gap between the big toe and second toe). A few people had heart defects, such as a hole in the heart (atrial septal defect or ventricular septal defect) or a narrowed heart valve (pulmonic stenosis).

  • 90 percent of people had feeding issues and constipation
  • 10 percent of people had heart defects

Where can I find support and resources?

2q23.1 Syndromes/MBD5 Disorders/MAND Caregiver Support Network

Simons Searchlight

Simons Searchlight is an online international research program, building an ever growing natural history database, biorepository, and resource network of over 175 rare genetic neurodevelopmental disorders. By joining their community and sharing your experiences, you contribute to a growing database used by scientists worldwide to advance the understanding of your genetic condition. Through online surveys and optional blood sample collection, they gather valuable information to improve lives and drive scientific progress. Families like yours are the key to making meaningful progress. To register for Simons Searchlight, go to the Simons Searchlight website at www.simonssearchlight.org and click “Join Us.”

Sources and References

The content in this guide comes from published studies about MBD5-related syndrome. Below you can find details about each study, as well as links to summaries or, in some cases, the full article.

  • de Masfrand, S., Cogné, B., Nizon, M., Deb, W., Goldenberg, A., Lecoquierre, F., Nicolas, G., Bournez, M., Vitobello, A., … & Isidor, B. (2024). Penetrance, variable expressivity and monogenic neurodevelopmental disorders. European Journal of Medical Genetics, 69, 104932. doi:10.1016/j.ejmg.2024.104932
  • Jiang, H., Mou, J., Zhao, Q., Ding, L., Wang, Y., Guo, X., & Yang, G. (2025). A novel intronic mutation in MBD5 results in autosomal dominant intellectual disability type 1 due to abnormal splicing. Molecular Genetics & Genomic Medicine, 13(7), e70121. doi:10.1002/mgg3.70121
  • Mullegama, S. V., Mendoza-Londono, R., & Elsea, S. H. MBD5 haploinsufficiency. 2022 Apr 28. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK390803/

Stay connected with Simons Searchlight

Join our newsletter to receive updates